Advertisement

Topics

FDA Prioritizes Reviews Of Opioid Overdose ANDAs

01:56 EDT 10 Jul 2019 | SCRIP

Opioid overdose treatments containing naloxone or nalmefene are now eligible for expedited ANDA review in a bid by the FDA...

      

Related Stories

 

Original Article: FDA Prioritizes Reviews Of Opioid Overdose ANDAs

NEXT ARTICLE

More From BioPortfolio on "FDA Prioritizes Reviews Of Opioid Overdose ANDAs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...